Imaging of HER2 with [(89)Zr]pertuzumab in Response to T-DM1 Therapy

Background: The success of human epidermal growth factor receptor 2 (HER2)-targeted therapy depends on accurate characterization of HER2 expression, but current methods available have several limitations. This study aims to investigate the feasibility of [(89)Zr]pertuzumab imaging to monitor early r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Biother Radiopharm
Egile Nagusiak: Massicano, Adriana V.F., Lee, Supum, Crenshaw, Bryant K., Aweda, Tolulope A., El Sayed, Retta, Super, Ian, Bose, Ron, Marquez-Nostra, Bernadette V., Lapi, Suzanne E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc., publishers 2019
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227434/
https://ncbi.nlm.nih.gov/pubmed/30676778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2018.2654
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak